About Us

We are a multinational biopharmaceutical company developing new treatments for unmet medical needs, in particular cancer, by harnessing and unleashing the power of the immune system.

Antharis utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates to provide solutions for patients suffering from diseases for which there are currently no satisfactory treatments.

Our company’s paradigm-shifting approach to science holds unique promise to change the status quo for the development and use of targeted immunotherapies to fight diseases more successfully than ever before.